Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
Gianluca Trifirò, Marco Massari, Roberto Da, Francesca Menniti‐Ippolito, Janet Sultana, Salvatore Crisafulli, Paolo Giorgi Rossi, Massimiliano Marino, Manuel Zorzi, Emanuela Bovo, Olivia Leoni, Monica Ludergnani, Stefania Spila Alegiani, ITA-COVID-19: RAAS inhibitor group, Stefania Spila Alegiani, Francesca Menniti‐Ippolito, Roberto Da, Marco Massari, Giuseppe Traversa, Graziano Onder, Gianluca Trifirò, Janet Sultana, Valentina Ientile, Salvatore Crisafulli, Paolo Giorgi Rossi, Roberto Grilli, Giulio Formoso, Massimiliano Marino, Massimo Vicentini, Olivia Leoni, Monica Ludergnani, Danilo Cereda, Eliana Ferroni, Stefano Guzzinati, Emanuela Bovo, Manuel Zorzi, Massimo Gion
Topics & Concepts
MedicineHazard ratioRetrospective cohort studyInternal medicineCohort studyProportional hazards modelPopulationCohortConfidence intervalEnvironmental healthCOVID-19 Clinical Research StudiesRenin-Angiotensin System StudiesLong-Term Effects of COVID-19